| Thursday, March 19th, 2026 | |
| 13:00 – 19:00 | REG SUMMIT Working Group Meetings |
| Friday, March 20th, 2026 | |
| 08:50 – 08:55 | Welcome Joan Β. Soriano, REG President |
| 08:55 – 10:25 | Environment Session – Exposures in real life Chair: Nikos Papadopoulos Controlling indoor air pollution - a midsummer night's dream Athanasios Nenes Who cares about pollen? Maria P. Plaza Breathing nanoplastics - how does it feel? Carlos Baeza-Martínez Q&A |
| 10:25 – 10:45 | Coffee Break |
| 10:45 – 11:55 | Session - Global Respiratory Health Perspectives Chair: Dermot Ryan Respiratory patients’ initiatives in a changing environment Pippa Powell IPCRG initiatives on global respiratory health Cláudia Vicente ERS perspective on global respiratory health Marc Miravitlles GINA & GOLD perspective on global respiratory health David Halpin Q&A |
| 11:55 – 12:40 | ILD/IPF Session Chair: Katerina Antoniou Can RWE help bring new ILD/IPF therapies to patients? Michael Gibbons Q & A |
| 12:40 – 13:30 | Lunch Break |
| 13:30 – 15:00 | COPD Session - Challenging current COPD management Chair: Antonio Anzueto T2-directed therapy in COPD - is this really the right approach? Nicolas Roche ICS - do they really modulate cardiovascular risk? Konstantinos Kostikas Introducing ICRA and first project: Data standards for multiple long-term conditions in patients with COPD – results of the Delphi Chris Gale Q & A |
| 15:00 – 15:20 | Coffee Break |
| 15:20 – 16:30 | Early Career Travel Grant Winners Chair: Alan Kaplan & Joan B. Soriano 6 (approx) x 5min presentations with Q & A for each |
| In the Respiratory hot seat – PRO & CONs | |
| 16:30 – 17:15 | Biologics in asthma are disease-modifying Chair: Arnaud Bourdin PRO: Florence Schleich CON: Christian Virchow |
| 17:15 – 18:00 | There is value in making an early diagnosis of COPD Chair: Therese Lapperre PRO: Klaus Rabe CON: Miguel Román |
| Saturday, March 21st, 2026 | |
| 09:00 – 10:15 | Remission in severe asthma – Insights from the International Severe
Asthma Registry (ISAR) Chair: David Price & Diahn-Warng Perng Impact of remission on long-term clinical outcomes of patients with severe asthma (SPOTLIGHT) Michael E. Wechsler & Ghislaine Scelo Impact of earlier access to biologics on remission and natural course of asthma (GLEAM) George Christoff & John Busby Relapse and its predictors among ISAR patients in remission 12 months after initiating biologics (SHINE) Luis Pérez-de-Llano & William Oswald ISAR's practice change goals in severe asthma, including the elimination of long-term OCS use (ENLIGHTEN) Giorgio Walter Canonica & Dominic A. Friston |
| 10:15 – 10:30 | Coffee Break |
| 10:30 – 12:00 | Novel approaches to patient management Chair: Walter Canonica AIT and biologics – a new treatment option? Désirée Larenas-Linnemann Small airways (SAD) and oscillometry Ron Dandurand Weight management in airways disease Alan Kaplan Q & A |
| 12:00 - 12:45 | REG-EAACI Joint session Chairs: Fulvio Braido & María José Torres López Moderate-severe rhinitis management Piotr Kuna Endotyping of CRS – necessity or luxury? Wytske Fokkens Q & A |
| 12:45 – 13:30 | Transformation of Respiratory Medicine – where are we going? Chair: Miguel Román Real-world implementation of science to inform evidence-based respiratory medicine Hilary Pinnock Impact of digitalisation Job van Boven Phenotyping asthma/COPD exacerbations in real-life to target management Mona Bafadhel |
| 13:30 | Meeting Close |
Key dates & Deadlines
| Early Registration Deadline: December 30, 2025 |
| Abstract Submission Deadline: January 31, 2026 |
| Notification of Abstracts Acceptance: February 27, 2026 |
| REG SUMMIT 2026: March 19-21, 2026 |
| Security Warning: Please be aware of fraudulent websites or emails being presented as coming from the official conference organiser or official housing office. read more |
